Pharmaceutical Investing BetterLife Obtains TD-0148A Behavioural Pharmacology Data Confirming its Projected Non-hallucinogenic Property
Cannabis Investing Lobe Sciences Sponsors the International Summit on Psychedelic Therapies for Mental Illness
Psychedelics Investing Awakn Life Sciences Signs MOU with NHS and University of Exeter with a View of Increasing Access to Psychedelic-Assisted Psychotherapy in the UK
Cannabis Investing Lobe Sciences Announces Common Stock to Trade Under the Symbol "LOBEF" in US Markets
Psychedelics Investing Levitee Labs Appoints Noha ElSayed as Executive Director for Levitee Clinics and Levitee Pharmacies in the Alberta Region
Psychedelics Investing Levitee Labs Appoints Noha ElSayed as Executive Director for Levitee Clinics and Levitee Pharmacies in the Alberta Region
Psychedelics Investing Levitee Labs Signs Letter of Intent to Acquire a Chain of Specialty Addiction Pharmacies Located in British Columbia
